Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene.

Respiratory medicine - 1 Sept 2012

Kordiak Jacek, Szemraj Janusz, Hamara Katarzyna, Bialasiewicz Piotr, Nowak Dariusz

Abstract excerpt

Exhaled breath condensate (EBC) contains extracellular DNA that may originate from pathological lesions of the respiratory tract and can be a genetic marker of pulmonary malignancy. We tested whether complete surgical excision of lung cancer will decrease exhalation of mutated KRAS oncogene. Fifty seven patients with clinical diagnosis of lung cancer and detectable KRAS mutations in pre-surgery EBC-DNA were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor
Share to Breath Tests

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Large Cell

Share to Carcinoma, Non-Small-Cell Lung

Share to Genes, ras

Share to Lung Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 22795503
DOI: 10.1016/j.rmed.2012.06.019

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene.PMID 22795503Read ↗

Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensateSemantic proximity Read ↗

Exhaled breath condensate efficacy to identify mutations in patients with lung cancer: A pilot study.Semantic proximity Read ↗

High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer.Semantic proximity Read ↗

Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.Semantic proximity Read ↗

Detection of K-ras Oncogene Mutations in Bronchoalveolar Lavage Fluid for Lung Cancer DiagnosisSemantic proximity Read ↗

Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.Semantic proximity Read ↗

K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report.Semantic proximity Read ↗

Concordance in molecular genetic analysis of tumour tissue, plasma, and exhaled breath condensate samples from lung cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.